Tiziana Tiziana生命科学从ALS协会获得新的ALS治疗试验的资金。 Tiziana Life Sciences gets funding for a new ALS treatment trial from the ALS Association.

Tiziana Tiziana生命科学获得ALS协会的资助,为治疗ALS或Lou Gehrig病进行临床试验。 Tiziana Life Sciences has received funding from the ALS Association to conduct a clinical trial for a new treatment for ALS, or Lou Gehrig's disease. 该试验将在 20 名患者中测试鼻内 foralumab，这是一种旨在减少神经炎症的疗法。 The trial will test intranasal foralumab, a therapy aimed at reducing neuroinflammation, in 20 patients. 赠款来自Hoffman ALS临床授标方案,该方案支持对潜在的ALS治疗进行早期试验。 The grant comes from the Hoffman ALS Clinical Trial Awards Program, which supports early-stage trials of potential new ALS treatments.